文献速递肺外科

电视胸腔镜与开胸肺叶切除术的90天死亡率:一项大型多中心队列研究

Ninety-Day Mortality of Thoracoscopic vs Open Lobectomy: A Large Multicenter Cohort Study.
PubMed 文献 · Ann Thorac Surg · 2022-08-18

该研究基于波兰国家肺癌登记库2007年1月1日至2018年7月30日接受肺叶切除术的非小细胞肺癌患者数据,纳入31433例,倾向性评分匹配后电视胸腔镜手术(VATS)组与开胸组各4946例。VATS组住院死亡率和90天死亡率均低于开胸组,且两组90天死亡率均约为住院死亡率的两倍。

要点

  • VATS肺叶切除术与开胸相比住院死亡率更低(0.9% vs 1.5%,P=.004)。
  • VATS组90天死亡率低于开胸组(1.8% vs 3.4%,P<.001)。
  • 两组90天死亡率均约为住院死亡率的两倍(VATS 1.8% vs 0.9%,开胸 3.4% vs 1.5%,均P<.001)。

核心结论

  • VATS肺叶切除术与开胸相比住院死亡率和90天死亡率更低,若可行应推荐用于肺癌治疗。
  • 患者出院后也应密切监测,因为90天死亡率显著高于住院死亡率。

研究设计与样本

  • 基于波兰国家肺癌登记库2007年1月1日至2018年7月30日接受肺叶切除术的非小细胞肺癌患者数据。
  • 纳入符合所有研究标准的31433例患者,经倾向性评分匹配后VATS组4946例与开胸组4946例进行比较。

主要发现

  • VATS组住院死亡率0.9% vs 开胸组1.5%(P=.004)。
  • VATS组90天死亡率1.8% vs 开胸组3.4%(P<.001)。
  • VATS组90天死亡率1.8% vs 住院死亡率0.9%(P<.001)。
  • 开胸组90天死亡率3.4% vs 住院死亡率1.5%(P<.001)。
  • VATS组术后并发症23.6% vs 开胸组31.8%(P<.001)。

临床怎么用

  • 作者认为若可行,VATS肺叶切除术应推荐用于肺癌治疗。
  • 作者建议患者出院后也应密切监测,因为90天死亡率显著高于住院死亡率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies have demonstrated a lower incidence of complications after video-assisted thoracoscopic surgery (VATS) lobectomy compared with thoracotomy, but the data on in-hospital and 90-day mortality are inconclusive. This study analyzed whether surgical approach, VATS or thoracotomy, was related to early mortality of lobectomy in lung cancer and determined the differences between in-hospital and 90-day mortality. METHODS: Data of all patients with non-small cell lung cancer who underwent lobectomy between January 1, 2007, and July 30, 2018, were retrieved from Polish National Lung Cancer Registry. Included were 31 433 patients who met all study criteria. After propensity score matching, 4946 patients in the VATS group were compared with 4946 patients in the thoracotomy group. RESULTS: Compared with thoracotomy, VATS lobectomy was related to lower in-hospital (1.5% vs 0.9%, P = .004) and 90-day mortality (3.4% vs 1.8%, P < .001). Mortality at 90 days was twice as high as in-hospital mortality in both the VATS (1.8% vs 0.9%, P < .001) and thoracotomy groups (3.4% vs 1.5%, P < .001). Postoperative complications were less common after VATS compared with thoracotomy (23.6% vs 31.8%, P < .001). CONCLUSIONS: VATS lobectomy is associated with lower in-hospital and 90-day mortality compared with thoracotomy and should be recommended for lung cancer treatment, if feasible. Patients should also be closely monitored after discharge from the hospital, because 90-day mortality is significant higher than in-hospital mortality.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Piwkowski C, Gabryel P, Campisi A, et al. Ninety-Day Mortality of Thoracoscopic vs Open Lobectomy: A Large Multicenter Cohort Study. Ann Thorac Surg. 2022. PMID: 35988738. doi:10.1016/j.athoracsur.2022.07.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。